Oncology Biomarker Initiative Will Adapt Existing Clinical Trials For Validation
First project under initiative by FDA, NCI and CMS will evaluate use of PET scans to predict early response in non-Hodgkin’s lymphoma patients.
First project under initiative by FDA, NCI and CMS will evaluate use of PET scans to predict early response in non-Hodgkin’s lymphoma patients.